Chief Executive Officer Gibson Christopher converted options into 120,000 shares, sold $471,000 worth of shares (100,000 units at $4.71) and gifted 20,000 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

RXRX· Recursion Pharmaceuticals Inc.

Health Care

Original source

Chief Executive Officer Gibson Christopher converted options into 120,000 shares, sold $471,000 worth of shares (100,000 units at $4.71) and gifted 20,000 shares (SEC Form 4) | Quantisnow